Company profile
Invitron Limited
Home - Invitron
Molecular Light Technology, acridinium ester chemiluminescence detection system used in high sensitivity medical diangnostic tests.
Latest accounts
Financial period: 1 Apr 2024 to 31 Mar 2025
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
A portable diagnostic device that provides the accuracy of laboratory testing at the point of care.
1 Oct 2023 to 31 Mar 2025
Most of us have experienced the anxious wait for laboratory test results. Whether it's a Covid-19 test completed before travel or a blood test carried out by our doctor, laboratory turn-around times can significantly impact on everyday life. For people living with chronic diseases like diabetes this stressful delay is not only more frequent but can hinder...
High Sensitivity Chemiluminescent Point of Care Tests for Cardiac Troponin
1 Feb 2017 to 31 Mar 2019
Point of care (POC) tests are rapid medical diagnostic tests designed to be carried out next to the patient. POC devices produce results much faster than laboratory tests which enable physicians and nurses to act sooner and thus save lives, improve patient outcomes and reduce overall costs to the healthcare system. However, more widespread use of POC test...
Chemiluminescent Point of Care Tests
1 Jul 2015 to 31 Dec 2016
Point of care tests (POCT) are rapid medical diagnostic tests designed to be carried out next to the patient. POCT devices produce results much faster than laboratory tests which enable physicians and nurses to act sooner and thus save lives, improve patient outcomes and reduce overall costs to the healthcare system. However, more widespread use of POCT i...